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Conclusion: Earl y lung cancer diagnosis with CT in HIV-infected smokers was feasible, 
safe, and yielded a significant number of cancers. Lung cancer screening of HIV­
infected smokers with an important history of immunodeficiency revealed a substantial 
number of cancers at younger ages than the targeted range in the general population. 
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Introduction Since the advent of combination antiretroviral therapy ( cART), a shift in mortality and morbidity has been observed in people living with HIV (PLWHIV) from AIDS to non-AIDS diseases, amongst which a high proportion of malignancies [1-3]. In this population, lung cancer incidence and mortality rate are the highest among ail the non-AIDS-defining malignancies [3-11]. Studies have also found increased standardized incidence ratios (SIR) of lung cancer in the HIV-infected in comparison to the general population [4,5,8, 12, 13], with increased rates even after adjusting for smoking [14]. However, smoking is the primary trigger of lung oncogenesis in the general [15] and the HIV-infected population, as reflected by nearly 100% smoking prevalence in published case series [14,16-18]. Lung cancers will remain frequent in PLWHIV as long as smoking prevalence in this population remains high. The randomized National Lung Screening Trial (NLST) showed a significant 20% lung cancer mortality reduction and a 6. 7% overall mortality reduction in smokers from the general population aged 55 to 74 years with three annual chest low dose computed tomography (LDCT) versus radiography [19]. Due to higher incidence of lung cancer, lung cancer screening with chest CT in PLWHIV could also be beneficial. However, because of the high prevalence of pulmonary morbidities, such as infectious events, chronic obstructive pulmonary disease (COPD) and emphysema in this population [20-23], chest CT might reveal many false positive nodules or other abnormalities, leading to inappropriate invasive diagnos­tic procedures with increased risks of complications. Thus, studies are needed to evaluate feasibility, benefits and harms of lung cancer screening in this population. We conducted a lung cancer early diagnosis programme with a single chest CT in PLWHIV in France. 
Methods 
Study design and participants This study was a multicentric prospective cohort of PLWHIV at risk for lung cancer followed for 2 years after assessment of potential lung cancer related images on a single chest CT. To be included, patients had to be infected with HIV and be smokers with a total uptake of at least 20 pack-years (possibly stopped in the last 3 years), be aged at least 40 years, to have a nadir CD4+ T-cell count less than 350 cells/ µl, a current CD4 + T-cell count at least 100 ceils/ µl, and a me di cal insurance coverage. We chose a nadir CD4 + T -cell count below 350 cells/ µl to select patients with a history of significant immunode­ficiency and a relatively long history of HIV exposure, and a last CD4 + value at least 100 ceils/ µl to minimize risk of infectious nodules. Patients were excluded in case of current active cancer or AIDS-classifying disease, lung infection within the previous two months, pregnancy, breastfeeding and contraindication to thoracic surgery. Patients were included in the study by their HIV-caring physician during routine visits in 14 clinical centres in France. The study was approved by the Research Ethics Committee of Montpellier Sud-méditerranée IV (No ID-RCB: 2010-A00781-38) prior to data collection and was conducted in accordance with the standards ofEthics Committee and the Helsinki Declaration. All study participants gave written informed consent. Procedures Ali chest CTwere acquired in 13 radiologie departments, ail from French university-hospital centres, usmg multi-detector row scanners without contrast material enhancement. The entire chest from apex to posterior recesses was included at end inspiration in one breath hold according to the protocol of the study (100 kVp, automated tube current modulation) with section thick­ness not greater than 1 mm. The median effective dose derived from the product of Dose Length Product and a conversion coefficient (k=0.014 mSv·mGy- 1·cm- 1) [24] was 2.97 mSV, interquartile range (IQR) of 1.99 to4.49 mSv. Though there is no standardized definitionof low dose in CT for lung cancer screening, actualirradiation goal is less than 2 mSV (1.5 mSV averageeffective dose in the NLST trial for instance [19]), to be putin perspective with a 8 mSV or higher effective dosein diagnostic CT. The effective dose in our study was thuslow to moderate according to cases. One radiologist fromeach centre read the CT and completed a standardizedreport.







